1.82
-0.03(-1.62%)
Currency In USD
| Previous Close | 1.85 |
| Open | 1.76 |
| Day High | 1.85 |
| Day Low | 1.79 |
| 52-Week High | 2.72 |
| 52-Week Low | 1.54 |
| Volume | 189,307 |
| Average Volume | 533,114 |
| Market Cap | 156.48M |
| PE | -6.07 |
| EPS | -0.3 |
| Moving Average 50 Days | 1.94 |
| Moving Average 200 Days | 2.06 |
| Change | -0.03 |
If you invested $1000 in Stereotaxis, Inc. (STXS) 10 years ago, it would be worth $866.67 as of April 22, 2025 at a share price of $1.82. Whereas If you bought $1000 worth of Stereotaxis, Inc. (STXS) shares 5 years ago, it would be worth $506.96 as of April 22, 2025 at a share price of $1.82.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025
GlobeNewswire Inc.
Yesterday at 12:00 PM GMT
GenesisX pairs clinical capability with broad accessibility in surgical roboticsST. LOUIS, April 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular interventio
Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program
GlobeNewswire Inc.
Mar 19, 2025 12:01 PM GMT
ST. LOUIS, March 19, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that NVIDIA highlighted Stereotaxis’ technology at NVIDIA GTC
Stereotaxis to Present at 37th Annual Roth Conference
GlobeNewswire Inc.
Mar 10, 2025 12:02 PM GMT
ST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the